Key facts
- Notable investors include Step Holdings, Win-Win Capital, Genuine Investment, Grand Yangtze Capital, Xingliang Investment — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Jieshi Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Jieshi Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jieshi Medical
Manufacturers of class III medical devices and translational genomics aim to accelerate innovation in gene-based treatments and clinical translation of advanced therapeutics. The company's primary operations include comprehensive gene research services, therapeutic target discovery and validation, and drug evaluation pipelines supporting cell and gene therapy development, enabling clients to streamline therapeutic development workflows, from target identification to early clinical stages, enhancing the pace and efficacy of bringing novel gene therapies.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2012
- Website
- sunvista.cn/
- Ownership
- Privately Held (backing)
Jieshi Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jieshi Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jieshi Medical in its N-PORT filings yet. We sweep new filings monthly.